Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer.

The decision aid appears to help breast cancer patients support their decision about whether to receive NAST. Patients' ability to review the decision aid in-between two consultations seems to be an acceptable and feasible way of integrating the decision aid into patients' care.